+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID05669222

Study Comparing FAST Technique Guided PCI Versus Standard Treatment in Patients With STEMI and Multivessel Coronary Disease

Led by China National Center for Cardiovascular Diseases · Updated on 2026-09-24

5000

Participants Needed

1

Research Sites

260 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating two different strategies for percutaneous coronary intervention PCI in patients with ST-segment elevation myocardial infarction STEMI who have disease in multiple coronary vessels. This study compares the Functional and Angiography-derived Strain inTegration FAST technique, which uses next-generation quantitative flow ratio QFR and radial wall strain RWS measurements, to a standard treatment strategy. The main goal is to see which approach leads to better long-term clinical outcomes, focusing on major adverse cardiac events including death, myocardial infarction, or ischemia-driven revascularization. Participants are randomly assigned to one of two groups. In the FAST guided group, QFR is measured in non-infarct arteries with specific lesion severity criteria, and PCI is performed based on QFR and RWS thresholds or lesion severity. Post-PCI QFR measurements guide further procedures if needed. In the standard treatment group, PCI is done on lesions with visual diameter stenosis 70% or more, and fractional flow reserve FFR or instantaneous wave-free ratio iFR guide treatment decisions for lesions with 50-70% stenosis. Patients are followed for several years with scheduled clinic visits or phone calls. During the study, participants will have follow-up visits or phone contacts at 1 month, 6 months, and annually up to 5 years. Researchers will monitor for major adverse cardiac events, cardiovascular death, and myocardial infarction, among other outcomes such as procedural success and quality of life. Safety and health status will be assessed regularly to understand the long-term impact of the two PCI strategies in this high-risk patient group.

CONDITIONS

Brief Title

The FAVOR V AMI Trial

Research Team

B

Bo Xu, MBBS

L

Lei Song, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here